Premature insulin treatment in T2DM leads to weight gain [97] and a high C-peptide concentration (indexing endogenous insulin release) may be related to microvascular damage [31], chemiotaxis of inflammatory cells and smooth muscle cells, and proliferation thus contributing to atherosclerosis [98]. This evidence concerns the gene INS and type 2 diabetes mellitus.